On strategic choices faced by large pharmaceutical laboratories and their effect on innovation risk under fuzzy conditions
Fecha de publicación:
2019
Versión del editor:
Citación:
Artificial Intelligence in Medicine, 100, p. 101703- (2019); doi:10.1016/j.artmed.2019.101703
Descripción física:
p. 101703-
ISSN:
Patrocinado por:
Fernando Gascón would like to acknowledge financing from the Spanish Ministry of Economy and Competitiveness and the European Regional Development Fund (ref. MINECO-16-ECO2015-66184-R). Besides, the authors would like to thank the advice and help of Amparo García-Ochoa and Pepe García.
Colecciones
- Artículos [37320]